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Autocrine IL-21 Stimulation Is Involved in the
Maintenance of Constitutive STAT3 Activation
in Se´zary Syndrome
Leslie van der Fits1, Jacoba J. Out-Luiting1, Marieke A. van Leeuwen2, Janneke N. Samsom2, Rein Willemze1,
Cornelis P. Tensen1 and Maarten H. Vermeer1
Se´zary syndrome (SS) is a cutaneous T-cell lymphoma (CTCL) with malignant CD4þ T cells (SS cells) in skin,
lymph nodes, and blood. Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in
SS cells, whereas this activation is lost upon in vitro culturing, indicating that STAT3 activation observed in vivo
is the result of activating factors in the micromilieu of the malignant cells. We investigated which factors are
involved in STAT3 activation in SS, focusing on cytokines of the common g-chain family because of their crucial
role in T-cell activation. Furthermore, downstream effects of STAT3 signaling in SS cells were assayed. In SS cells,
STAT3 was strongly activated by IL-21, and increased expression of IL-21 and its receptor chains was observed in
peripheral blood SS cells. IL-21 and IL-21R protein expression was detectable on neoplastic cells in SS skin
biopsies. Using short-term culturing experiments, we demonstrate that IL-21 itself and the a-chain of the IL-2
receptor are STAT3 target genes in SS cells, thereby rendering cells more sensitive to stimulation with the T-cell
proliferation and activating cytokine IL-2. Combined, our data point toward a pivotal role for an autocrine
positive feedback loop involving IL-21 and consequent persistent STAT3 activation in the pathogenesis of SS,
thereby indicating IL-21 and IL-21R as new therapeutical targets.
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INTRODUCTION
Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous
group of T-cell neoplasms that primarily arise in the skin.
Mycosis fungoides, the most common form of CTCL, is a
mostly indolent neoplasm that can evolve from skin patches
to plaques and eventually tumors containing skin-homing
CD4þ memory T cells. Se´zary syndrome (SS) is a rare
leukemic form of CTCL, often with an aggressive clinical
course. It is characterized by generalized erythroderma,
lymphadenopathy, and the presence of neoplastic CD4þ
T cells (SS cells) in skin, lymph nodes, and peripheral blood.
Persistent activation of transcription factors of the signal
transducers and activators of transcription (STAT) protein
family has been implicated in the pathogenesis of a wide
variety of human cancers, including CTCL. Constitutive
STAT3 activation (phosphorylation) was observed in SS cells
in the peripheral blood (Zhang et al., 1996; Nielsen et al.,
1999; Eriksen et al., 2001; van Kester et al., 2008), as well as
in malignant T lymphocytes in skin samples from mycosis
fungoides tumors and SS (Qin et al., 2001; Sommer et al.,
2004). We previously demonstrated that the STAT3 phos-
phorylation is lost upon in vitro culturing of SS cells (van
Kester et al., 2008), indicating that the activation observed
in vivo is the result of STAT3-activating factors present in the
micromilieu of the malignant cells.
Cytokines of the common g-chain (gc) family are capable of
activating STAT3 in various cell types (Yu and Jove, 2004), and
have a crucial role in normal T-cell physiology (Rochman
et al., 2009). Therefore, a putative role for several of these gc
cytokines in the pathogenesis of CTCL has been investigated
previously. IL-2, IL-7, and IL-15 can increase the survival of
CTCL cells in vitro (Dobbeling et al., 1998; Yamanaka et al.,
2006), and increased expression of IL-7 and IL-15 was
demonstrated in skin and peripheral blood from CTCL patients
(Dalloul et al., 1992; Foss et al., 1994; Dobbeling et al., 1998;
Leroy et al., 2001; Yamanaka et al., 2006).
IL-21 is the most recently discovered member of the
gc family of cytokines. It is produced by activated CD4þ
T cells, natural killer (NK) T cells, T follicular helper cells,
and T helper 17 (Th17) cells (Monteleone et al., 2009). Its
receptor is a dimer comprising the gc chain with its own
unique IL-21-specific receptor chain (IL-21R). IL-21R is
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expressed in a variety of immune cells, including B cells, T
cells, NK cells, and dendritic cells, as well as in nonimmune
cells such as endothelial cells, fibroblasts, and epithelial cells
(Monteleone et al., 2008, 2009). IL-21 expression in T cells
can be regulated by IL-21 via an autocrine positive feedback
loop, involving the activation of STAT3 (Caprioli et al., 2008).
This feedback loop is essential for the development of Th17
cells (Nurieva et al., 2007; Wei et al., 2007), and is involved
in Th17-mediated autoimmune diseases such as rheumatoid
arthritis (Niu et al., 2010).
In this study, we aimed to identify factors that are involved
in the maintenance of persistent STAT3 activation in SS, and
investigated the existence of an autocrine feedback loop in
persistent STAT3 activation. In addition, a role for IL-2RA as
STAT3 target gene in the oncogenic process is explored.
RESULTS
STAT3 is activated by IL-21, whereas other common
c-cytokines mainly activate STAT5 in Se´zary cells
We previously demonstrated that the persistent STAT3
activation that is observed in vivo is lost upon in vitro
culturing of primary SS cells (van Kester et al., 2008),
indicating that autocrine or paracrine STAT3 activation has a
role in vivo. We assayed STAT3 activation in SS cells, thereby
focusing on cytokines of the common g-chain family. Our
data show that STAT3 was consistently activated by IL-21 in
all patients studied (n¼ 6; Figure 1a), whereas IL-2, IL-7, and
IL-15 mainly activated STAT5 (Figure 1b). These data,
together with previously published results by Marzec et al.
(2008), demonstrate that IL-21 is a very potent activator of
STAT3, and prompted us to investigate whether autocrine or
paracrine stimulation of SS cells by IL-21 might be involved
in the constitutive activation of STAT3 in vivo.
The expression of IL-21R and IL-21 is increased
in peripheral blood Se´zary cells
The expression of the IL-21 receptor was analyzed on CD4þ T
cells in the peripheral blood of SS patients. mRNA expression
of both chains of the IL-21 receptor (common g-chain (gc) and
IL-21R) was significantly increased in CD4þ T cells from
peripheral blood of SS patients when compared with CD4þ T
cells of healthy donors (Figure 2). In contrast, no significantly
increased IL-21R and gc mRNA expression was observed in
the activated CD4þ T cells of patients with benign
erythroderma when compared with healthy controls (Figure 2).
Correlation analysis (Pearson’s) revealed a significant correla-
tion between the mRNA expression of gc and IL-21R, in line
with their coexpression in a single complex (P¼ 0.019).
Flow cytometric analysis of IL-21R protein showed that
B15% of the CD4þ lymphocytes stain positive for IL-21R,
both in the peripheral blood of healthy donors and patients
with SS (Figure 3a). As in the SS patients, who were analyzed
by flow cytometry, over 94% of the CD4þ T cells reacted
with a single Vb-specific antibody, verifying their clonal
origin (data not shown), our data demonstrate the existence of
IL-21R-negative and -positive subpopulations of SS cells.
Analysis of the CD4-negative nontumor lymphocytes (includ-
ing B cells, NK cells, and CD8þ T cells) demonstrates that a
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Figure 1. STAT3 is activated by IL-21, whereas other common c-cytokines
mainly activate STAT5 in Se´zary cells. CD4þ T cells were isolated from
peripheral blood of Se´zary patients (n¼6), and stimulated for 15minutes
with various common g-cytokines. (a) STAT3 and (b) STAT5 activation was
assayed by flow cytometry using an antibody specific for phosphorylated (P-)
STAT3 or STAT5. Each symbol represents the median fluorescent intensity of
P-STAT expression in an individual patient relative to the expression in
unstimulated cells. The mean is indicated with a horizontal line, and
statistically significant differences when compared with unstimulated cells
are indicated (Mann–Whitney test).
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Figure 2. mRNA expression of IL-21 and its receptors are increased in
peripheral blood Se´zary cells. RNA was extracted from CD4þ T cells
isolated from peripheral blood from healthy controls (HC), patients with
benign erythroderma (BE), or patients with Se´zary syndrome (SS). Expression
of both chains of the IL-21 receptor (common g-chain (gc) and IL-21-specific
receptor chain (IL-21R)), as well as IL-21 itself, was assayed by quantitative
reverse transcriptase-PCR (RT-PCR) and normalized for expression of a stably
expressed reference gene (ribosomal protein S11 (RPS11)). Each symbol
represents the expression in an individual patient, and the mean is indicated
with a horizontal line. Statistically significant differences (Po0.05;
Mann–Whitney test) are indicated.
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substantial proportion (30–70%) expresses IL-21R in both
healthy donors and SS patients (Figure 3c).
We additionally determined the level of IL-21R protein
expression on the IL-21R-positive subpopulations. IL-21R-
positive CD4þ SS cells expressed significantly higher levels
of IL-21R when compared with IL-21R-postive CD4þ cells
from healthy donors (Figure 3b). This is likely not just a
consequence of T-cell activation, as IL-21R protein expres-
sion was not increased upon stimulation of peripheral blood
mononuclear cells with phytohemagglutinin (data not
shown). In contrast, IL-21R expression was similar in
IL-21R-positive nontumor cells (CD4-negative lymphocytes)
from healthy donors and SS patients (Figure 3d), demonstrat-
ing that the increased IL-21R expression by CD4þ SS cells is
specific for the tumor cells, and not a generalized feature of
all lymphocyte subsets in these patients.
Furthermore, the expression of the cytokine IL-21 in
peripheral blood Se´zary cells was analyzed. Very low IL-21
mRNA expression was detectable in CD4þ T cells from
healthy donors and from patients with benign erythroderma,
whereas IL-21 expression in Se´zary patients was significantly
elevated (Figure 2). IL-21 protein levels in the serum were
assayed by ELISA. However, in most samples from controls
and from SS patients, IL-21 levels were below the detection
limit of the ELISA (o95 pgml–1; data not shown).
Altogether, our data suggest that increased IL-21 expres-
sion, together with an increased expression of its receptor,
might be involved in autocrine activation of STAT3 by IL-21
in peripheral blood Se´zary cells.
SS cells in skin biopsies are positive for both IL-21
and its receptor
To investigate the possibility that IL-21 activates STAT3 in
Se´zary cells in the skin, immunohistochemical analysis of
Se´zary skin biopsies (n¼ 4) was performed. Se´zary cells were
identified on the basis of morphology, size, and immuno-
phenotypical analysis of serial sections. Antibodies
against phosphorylated STAT3 showed that activated STAT3
protein is present in the nucleus of SS cells, as well as in
nonmalignant cells (Figure 4). Although staining of the skin
biopsies with an antibody against IL-21 resulted in a
brownish background staining, clear cytoplasmic staining
was detectable in cells morphologically resembling SS cells
(indicated with arrows in Figure 4). In contrast, most cells
with a normal nuclear morphology were IL-21 negative
(indicated with arrowheads in Figure 4). Immunohistochem-
ical staining with an antibody against IL21R revealed weak
positivity of Se´zary cells (indicated with arrows in Figure 4),
as well as of many other cell types present in the biopsies.
IL-21 expression is regulated by a positive feedback loop
via STAT3
Recently, it was demonstrated that the IL-21 gene itself is a
direct STAT3 target gene in healthy human T cells, thereby
creating a positive feedback loop (Caprioli et al., 2008). We
stimulated purified CD4þ SS cells with recombinant IL-21 for
various time points and determined IL-21 mRNA expression
by quantitative reverse transcriptase-PCR (RT-PCR). IL-21
expression was strongly and transiently increased, with a
maximum induction observed after 2 hours (Figure 5). To
assess whether this induction was dependent on STAT3
signaling, SS cells were pretreated with the known STAT3
inhibitor Cucurbitacin I (Blaskovich et al., 2003; van Kester
et al., 2008), resulting in complete inhibition of IL-21-induced
STAT3 activation, whereas IL-2-induced STAT5 activation
was only marginally affected (data not shown). IL-21-induced
expression of IL-21 mRNA was completely abrogated upon
pretreatment of the SS cells with cucurbitacin I (Figure 5).
Identical observations were made in CD4þ cells from four SS
patients and four healthy donors.
Se´zary cells are sensitized for IL-2 stimulation via
the IL-21/STAT3 axis
To fully understand the pathological role of STAT3 in SS,
identification of its downstream targets is mandatory. It was
shown previously that in human T cells, IFN-a enhances the
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Figure 3. Increased IL-21-specific receptor (IL-21R) protein expression on
peripheral blood Se´zary cells. IL-21R expression was determined by flow
cytometry on peripheral blood mononuclear cells from healthy controls
(HC, n¼ 4) and patients with Se´zary syndrome (SS, n¼4). The percentage of
IL-21Rþ cells was assayed in the (a) CD4þ and (c) CD4 lymphocytes.
In addition, the median fluorescent intensity (MFI) of the IL-21R expression
on (b) IL-21Rþ CD4þ and (d) IL-21Rþ CD4 lymphocytes is depicted.
Each symbol represents the percentage or expression in an individual patient,
and the mean is indicated with a horizontal line. Statistically significant
differences (Po0.05; Mann–Whitney test) are indicated.
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binding of STAT3 to the promoter of the a-chain of the IL-2
receptor (IL-2RA, CD25), resulting in increased IL-2RA
expression and IL-2 sensitivity (Matikainen et al., 1999).
We therefore assessed IL-2RA mRNA expression in CD4þ
cells that were isolated from the peripheral blood from
healthy donors, patients with benign erythroderma, and SS
patients. CD4þ cells from patients with benign erythro-
derma display high levels of IL-2RA (Figure 6a), indicative of
their activated phenotype (CD25high). In addition, in SS cells,
IL-2RA mRNA expression is significantly elevated when
compared with healthy controls (Figure 6a), in line with the
constitutive STAT3 activation that is observed in SS cells
in vivo. Culturing primary CD4þ SS cells with IL-21 resulted
in a transient induction of IL-2RA mRNA expression,
with a maximum induction after 2 hours and a return to
baseline expression after 8 hours (Figure 6b). Pretreatment
of cells with the STAT3 inhibitor cucurbitacin I resulted
in a complete abrogation of IL-21-induced IL-2RA mRNA
expression, demonstrating that this effect is mediated via
STAT3 (Figure 6b). This induction pattern was identical in
CD4þ cells from SS patients (n¼3), as well as from healthy
donors (n¼3).
We furthermore assayed whether the increased IL-2RA
expression had functional consequences for the IL-2 sensi-
tivity. SS cells were preincubated with IL-21 to induce IL-2RA
expression, and subsequently stimulated with IL-2. As IL-2
stimulation results in phosphorylation of STAT5 in SS cells,
we quantified STAT5 activation as readout for the IL-2
responsiveness. Our data show that in three out of five
patients, pretreatment of SS cells with IL-21 results in a more
pronounced IL-2-induced STAT5 phosphorylation, indicative
of an increased IL-2 sensitivity (Figure 6c).
Thus, our data suggest that SS cells are sensitized for IL-2
stimulation via upregulation of the a-chain of the IL-2
receptor via the IL-21/STAT3 pathway.
DISCUSSION
In this paper, we demonstrate that IL-21 is expressed by SS
cells in peripheral blood and skin, and is a very potent
HE P-STAT3 IL-21 IL-21R
Figure 4. IL-21 and IL-21-specific receptor (IL-21R) expression in Se´zary syndrome (SS) cells in skin biopsies. Skin biopsies from SS patients (n¼ 4) were
stained with hematoxylin and eosin (HE), and with antibodies against P-STAT3, IL-21, and IL-21R. IL-21-expressing SS cells are indicated by arrows,
whereas IL-21-negative cells are indicated by arrowheads. Furthermore, SS cells weakly positive for IL-21R are indicated with arrows. Representative
examples are shown. Bar¼ 100 mm.
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Figure 5. IL-21 mRNA expression is regulated by a positive feedback loop
via STAT3. CD4þ cells were isolated from peripheral blood of Se´zary
patients. Cells were pretreated with cucurbitacin I (CucI) or DMSO for
2 hours, and stimulated with IL-21 for various time points. IL-21 mRNA
expression was determined by quantitative reverse transcriptase-PCR
(RT-PCR), and expressed relative to mRNA levels of a housekeeping gene
(ribosomal protein S11 (RPS11)).
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activator of STAT3 signaling. As IL-21 itself is a STAT3 target
gene in SS cells, persistent STAT3 activation in SS cells
in vivo might be maintained via an autocrine positive
feedback loop involving IL-21. Identification of this loop
thereby provides new insights into the pathogenic process of
SS, potentially indicating IL-21 and IL-21R as new thera-
peutical targets.
IL-21 can have complex activities on various cell types,
resulting in enhancement of adaptive T-cell immunity,
antibody production, activation, and maturation of NK
cells, and impairment of regulatory T-cell development and
function (Davis et al., 2007). As a consequence, IL-21 has
been implicated in the pathogenesis of T-cell-mediated
inflammatory (autoimmune) diseases such as psoriasis,
rheumatoid arthritis, and systemic lupus erythematosus
(Monteleone et al., 2009), thereby making IL-21-inhibiting
strategies emerging therapeutic options. On the other
hand, boosting IL-21 activity can be beneficial for immuno-
therapy for cancer by augmentation of CD8þ and NK cell
activity. This antitumor activity of IL-21 has been demon-
strated in various preclinical mouse tumor models, as well
as in phase I clinical trials in patients with advanced
metastatic melanoma and renal cell carcinoma (Spolski and
Leonard, 2008).
However, it was demonstrated previously that IL-21 also
has direct effects on IL-21Rþ lymphoid neoplastic cells.
IL-21 promotes the growth of multiple myeloma (Brenne
et al., 2002), anaplastic lymphoma kinase–expressing ana-
plastic large-cell lymphoma (Dien Bard et al., 2009), and
adult T-cell leukemia (Ueda et al., 2005), and protects
Hodgkin’s lymphoma cells from apoptosis (Lamprecht et al.,
2008). On the contrary, IL-21 can induce apoptosis in
follicular lymphoma cells (Akamatsu et al., 2007; de Totero
et al., 2010), B-chronic lymphocytic leukemia (de Totero
et al., 2006, 2008; Gowda et al., 2008), and diffuse large
B-cell lymphoma (Sarosiek et al., 2010). The effects of IL-21
on proliferation and survival of CTCL cells have been studied
previously. Culturing CTCL cells with IL-21 protects them
from apoptosis, without affecting their proliferation (Marzec
et al., 2008; Yoon et al., 2008). We here demonstrate that
STAT3 in SS cells is activated by IL-21 in an autocrine
manner. Malignant cells from patients with Hodgkin’s
lymphoma aberrantly produce IL-21 and its receptor, result-
ing in autocrine STAT3 activation, upregulation of STAT3
target genes, and protection of the Hodgkin/Reed–Stenberg
cells from apoptosis (Lamprecht et al., 2008). In analogy, a
similar role for the IL-21/STAT3 axis might be involved in the
protection of SS cells from apoptosis.
Autocrine activation of T cells by IL-21 was previously
demonstrated to be indispensable for the development of
murine Th17 cells (Nurieva et al., 2007; Wei et al., 2007).
Furthermore, Th17 cytokines IL-17 and IL-21 are direct Stat3
target genes in mice (Durant et al., 2010). Very recently, it
was shown that malignant cells in skin lesions of patients with
SS and mycosis fungoides express IL-17, and that this IL-17
expression is regulated via the STAT3 pathway (Krejsgaard
et al., 2011). Together with our data demonstrating STAT3-
dependent expression of IL-21 in SS cells, this implicates that
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Figure 6. IL-21/STAT3 signaling renders SS cells more sensitive to IL-2.
(a) IL-2RA mRNA expression was assayed in RNA in CD4þ T cells from
healthy controls (HC), patients with benign erythroderma (BE), or patients
with Se´zary syndrome (SS) using quantitative reverse transcriptase-PCR
(RT-PCR), and normalized for ribosomal protein S11 (RPS11) expression.
Each symbol represents expression in an individual patient, and the mean is
indicated with a horizontal line. Statistically significant differences (Po0.05;
Mann–Whitney test) are indicated. (b) SS cells were pretreated with
cucurbitacin I (CucI) or DMSO for 2 hours, and stimulated with IL-21 for the
time points indicated. IL-2RA mRNA expression was determined as in a. (c) SS
cells from five patients were incubated overnight with or without IL-21, and
subsequently stimulated with IL-2 for 15minutes. Phosphorylated (P-) STAT5
expression was assayed by flow cytometry, and the median fluorescent
intensities (MFIs) of the P-STAT5 staining were calculated relatively to the
P-STAT5 MFI in unstimulated cells for each patient.
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STAT3 signaling is involved in the regulation of Th17
cytokine expression in CTCL cells.
Our immunohistochemical analysis of SS skin biopsies
showed weak expression of IL-21R on not only SS cells, but
also on many other cell types including keratinocytes. These
data are in line with previous reports demonstrating relatively
high expression of IL-21R on keratinocytes in patients with
systemic sclerosis and atopic dermatitis, and weak expression
in healthy skin (Distler et al., 2005; Jin et al., 2009). In
addition, in vitro stimulation of keratinocytes with IL-21
induces cell proliferation (Caruso et al., 2009), suggestive of a
functional IL-21R on this cell type. It is conceivable that the
expression of activated STAT3 in keratinocytes in SS biopsies
(Figure 4) results from paracrine activation by IL-21 produced
by SS cells. The functional consequence of this paracrine
activation remains to be elucidated; in particular, the
question of whether this activation of keratinocytes leads to
cytokine production that reciprocally affects SS cells needs to
be addressed.
A previous microarray study by Marzec et al. (2008)
demonstrated that only a very limited number of genes are
upregulated by IL-21 in a CTCL cell line. This list included
IL-2RA, but lacked other genes for which we show
upregulation by IL-21, such as the IL-21 gene itself (this
study) and miR-21 (van der Fits et al., 2011). We think that
this discrepancy is due to the early and transient nature of
induction of genes by IL-21, whereas the microarray analysis
to identify IL-21-responsive genes was conducted at a single
time point (4 hours).
In this study, we demonstrate that IL-21 stimulation of
primary SS cells results in significantly increased IL-2RA
mRNA expression (Figure 6b), resulting in increased IL-2
sensitivity in three out of five patients (Figure 6c). However,
we were unable to demonstrate increased IL-2RA protein
(CD25) expression on IL-21-stimulated SS cells (n¼5, data
not shown). This discrepancy might have methodological
causes, e.g., differences in sensitivity of the different assays
(flow cytometry vs. quantitative RT-PCR). Furthermore, the
transient nature of the induction of IL-2RA mRNA expression
by IL-21 might interfere with the detection of increased
IL-2RA protein expression. Alternatively, the lack of IL-21-
induced expression of cell-surface IL-2RA might be caused by
proteolytic cleavage of IL-2RA from the cell membrane,
resulting in secretion of soluble CD25 (sCD25). Stimulation
of CTCL cell lines with IL-21 results in increased secretion of
sCD25 (Kasprzycka et al., 2008), and serum sCD25 levels are
elevated in SS patients and correlate with the clinical course
and a poor prognosis (Bernengo et al., 1993; Wasik et al.,
1996). However, it is currently unknown how sCD25 is
involved in the pathogenesis of cutaneous lymphoma.
In summary, we demonstrate that IL-21 can contribute to
the constitutive STAT3 activation that is observed in SS cells
via a positive autocrine feedback loop. The continuous
activation of this loop renders cells more resistant to
apoptosis, and more sensitive to T-cell proliferation and
stimulation of cytokine IL-2. This will make this axis
potentially interesting for therapeutic intervention by target-
ing STAT3 or the IL-21/IL-21R couple.
MATERIALS AND METHODS
Patient selection
SS patients (5 men and 10 women, median age 62 years) were
diagnosed on the basis of criteria of the World Health Organization
(WHO)/European Organization for Research and Treatment of
Cancer (EORTC) 2005 classification (Willemze et al., 2005; Olsen
et al., 2007). As control groups, patients with erythroderma
secondary to atopic dermatitis (benign erythroderma) and healthy
donors were included.
Approval for these studies was obtained from the Leiden
University Medical Center review board, and informed consent
was provided according to the Declaration of Helsinki Principles.
Cell culturing and stimulation experiments
Heparinized blood was drawn, and peripheral blood mononuclear
cells were isolated by Ficoll density centrifugation. From this
fraction, CD4þ T cells were isolated by negative selection with
magnetic beads (CD4þ T cell isolation kit; Miltenyi Biotec, Bergisch
Gladbach, Germany). The purity of the CD4þ cell population was
verified by flow cytometric analysis for CD3, CD4, and CD8
expression, and was generally 485%. In addition, earlier experi-
ments demonstrated that 490% of the CD4þ cells comprise
malignant cells characterized by expression of a clonally rearranged
T-cell receptor.
Cells were cultured in RPMI-1640 supplemented with 10%
human AB serum (Greiner Bio-One, Alphen aan den Rijn, The
Netherlands), 2mM L-glutamine, 100Uml–1 penicillin, 100mgml–1
streptomycin, 200Uml–1 IL-2, and 5 ngml–1 IL-7 (PeproTech, Rocky
Hill, NJ).
Cells used for stimulation experiments were grown overnight in
cytokine-deprived medium, and subsequently stimulated with IL-2
(200Uml–1), IL-7 (10 ngml–1), IL-15 (20 ngml–1; all from PeproTech),
or IL-21 (100 ngml–1; ImmunoTools, Friesoythe, Germany). Cucur-
bitacin I (Indofin, Hillsborough, NJ) was dissolved in DMSO in a
concentration of 50mM, and diluted in culture medium to a final
concentration of 30 mM.
Flow cytometry
The expression of activated STAT3 and STAT5 was determined by
flow cytometry using antibodies specifically recognizing phospho-
rylated STATs, as previously described (van der Fits et al., 2011).
In brief, cells were fixed in 4% paraformaldehyde in phosphate-
buffered saline and subsequently permeabilized in 90% ice-cold
methanol. After washing, cells were stained with Alexa647-
conjugated antibodies against P-STAT3 (Tyr705), and with phyco-
erythrin-conjugated antibodies against P-STAT5 (Tyr694) (BD
Biosciences, Franklin Lakes, NY).
Flow cytometric analysis of IL-21R was performed in
non-fixed peripheral blood mononuclear cells, using a rabbit
anti-IL-21R antibody (Abcam, Cambridge, UK), followed by FITC-
conjugated goat anti-rabbit (Invitrogen, Carlsbad, CA) as a secon-
dary antibody, in combination with anti-CD4-PerCP-Cy5.5 (BD
Biosciences).
Samples were acquired on a flow cytometer (FacsCalibur,
BD Biosciences), and analyzed using CellQuest software (BD
Biosciences). Lymphocytes were gated on the basis of their forward
and sideward scatter patterns, and IL-21R expression was assayed on
CD4þ and CD4 lymphocytes separately.
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Quantitative RT-PCR
The mRNA expression levels of IL-21, IL-21R, gc, and IL-2RA was
assayed by quantitative RT-PCR. Total RNA was isolated from 1 to
10 106 cells using the RNeasy Mini kit (Qiagen), treated with RQ1
DNase I (Promega, Madison, WI), and converted into complemen-
tary DNA using IScript reverse transcriptase (Bio-Rad, Hemel
Hempstead, UK), oligo(dT)1218, and random hexamer primers
(Bio-Rad). Real-time PCR was performed using the IQ5 instrument
and SYBR Green Supermix (Bio-Rad), using the following cycle
parameters: 5minutes at 95 1C, followed by 45 cycles of 15 seconds
at 97 1C, and 30 seconds at 60 1C. Sequences of the primers
used were as follows: IL-21-forward 50-CCTGGCAACATGGAGAGG
ATTG-30; IL-21-reversed 50-TGTGGCGATCTTGACCTTGGG-30;
IL-21R-forward 50-CCTCACCTGCTGCTTCTCCTC-30; IL-21R-rever-
sed 50-TCTTCTTCCATAGCCTCCACAATG-30; gc-forward 50-AATTC
CCACCCTGAAGAACCTAGAG-30; gc-reversed 50-CAGCCAGTCC
CTTAGACACACC-30; IL-2RA-forward 50-GCGGAGACAGAGGAAG
AGTAGAAG-30; IL-2RA-reversed 50-GCAGGCAAGCACAACGG
ATG-30; RPS11 (ribosomal protein S11) as described previously
(Zuidervaart et al., 2003). Data were analyzed using IQ5 software
using the DDCt method (Bio-Rad), and expressed relative to mRNA
expression levels of the stably expressed reference gene RPS11.
Specificity of the PCR products was confirmed by melting curve
analysis.
Immunohistochemistry
Immunohistochemical staining was performed on 3mm sections of
formalin-fixed, paraffin-embedded skin samples using standard
procedures. After antigen retrieval by boiling for 10minutes in
10mM citrate buffer (pH 6.0), tissue sections were incubated with
primary antibodies against P-STAT3 (Tyr705; Cell Signaling Techno-
logy, Danvers, MA), IL-21R (Abcam), or IL-21 (Lifespan Biosciences,
Seattle, WA). Subsequently, sections were incubated with Bright-
Vision-HRP (Immunologic, Duiven, The Netherlands), biotinylated
swine anti-rabbit-IgG (DAKO, Glostrup, Denmark), followed by the
VectaStain ABC kit (Vector Laboratories, Burlingame, CA), or biotinyl-
ated goat anti-rabbit-IgG (Vector Laboratories), followed by
streptavidin–biotin–peroxidase complex (DAKO), respectively. Immu-
noreactivity was detected using diamino-benzidine or 3-amino-9-
ethylcarbazole, and slides were counterstained with hematoxylin.
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